Yuya Ito

Yuya Ito

Auto-generated profile, based on publicly available information

Yuya Ito

Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
YIYuya Ito
Yuya Ito
TTTakahiro Takazono
Takahiro Takazono
YOYasushi Obase
Yasushi Obase
SFSusumu Fukahori
Susumu Fukahori
NANobuyuki Ashizawa
Nobuyuki Ashizawa
HMHiroshi Mukae
Hiroshi Mukae
Allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) are important fungal infections caused by Aspergillus species. An overlap of ABPA and CPA has been reported; therefore, it is critical to determine whether the main pathology is ABPA or CPA and whether antifungals are required. In this study, we investigated whether the serum cytokine profile is useful for understanding the pathology and for differentiating between these diseases. We compared the various serum cytokine levels among healthy subjects and patients diagnosed with asthma, ABPA, or CPA at Nagasaki University Hospital between January 2003 and December 2018. In total, 14 healthy subjects, 19 patients with asthma, 11 with ABPA, and 10 with CPA were enrolled. Interleukin (IL) -5 levels were significantly higher in patients with ABPA than in those with CPA, and IL-33 and tumor necrosis factor (TNF) levels were significantly higher in patients with CPA than in those with asthma (p < 0.05, Dunn’s multiple comparison test). The sensitivity and specificity of the IL-10/IL-5 ratio (cutoff index 2.47) for diagnosing CPA were 70% and 100%, respectively. The serum cytokine profile is useful in understanding the pathology of ABPA and CPA, and the IL-10/IL-5 ratio may be a novel supplemental biomarker for indicating the pathology of CPA.

18 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
NNNana Nakada
Nana Nakada
KYKazuko Yamamoto
Kazuko Yamamoto
MTMoe Tanaka
Moe Tanaka
HAHiroki Ashizawa
Hiroki Ashizawa
MYMasataka Yoshida
Masataka Yoshida
HMHiroshi Mukae
Hiroshi Mukae
Severe fever with thrombocytopenia syndrome (SFTS) and Japanese spotted fever (JSF; a spotted fever group rickettsiosis) are tick-borne zoonoses that are becoming a significant public health threat in Japan and East Asia. Strategies for treatment and infection control differ between the two; therefore, initial differential diagnosis is important. We aimed to compare the clinical characteristics of SFTS and JSF based on symptomology, physical examination, laboratory data, and radiography findings at admission. This retrospective study included patients with SFTS and JSF treated at five hospitals in Nagasaki Prefecture, western Japan, between 2013 and 2020. Data from 23 patients with SFTS and 38 patients with JSF were examined for differentiating factors and were divided by 7:3 into a training cohort and a validation cohort. Decision tree analysis revealed leukopenia (white blood cell [WBC] < 4000/μL) and altered mental status as the best differentiating factors (AUC 1.000) with 100% sensitivity and 100% specificity. Using only physical examination factors, absence of skin rash and altered mental status resulted in the best differentiating factors with AUC 0.871, 71.4% sensitivity, and 90.0% specificity. When treating patients with suspected tick-borne infection, WBC < 4000/µL, absence of skin rash, and altered mental status are very useful to differentiate SFTS from JSF.

24 August 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
RORyo Ogata
Ryo Ogata
TKTakashi Kido
Takashi Kido
KTKazuaki Takeda
Kazuaki Takeda
KNKazuki Nemoto
Kazuki Nemoto
RHRiko Heima
Riko Heima
HMHiroshi Mukae
Hiroshi Mukae
Sarcoidosis is a systemic inflammatory disease characterized by noncaseating epithelioid cell granulomas. However, certain infections can exhibit similar histological findings. We present a case of a 69-year-old man who was initially diagnosed with sarcoidosis and later was confirmed, through 16S rRNA sequencing, to have disseminated Mycobacterium genavense infection. Acid-fast bacteria were detected in the bone marrow biopsy using Ziehl–Neelsen staining, but routine clinical tests did not provide a definitive diagnosis. The patient tested negative for HIV, anti-interferon-gamma antibodies, and genetic immunodeficiency disorders. He was treated with multiple drugs, including aminoglycosides and macrolides, but showed no improvement in fever and pancytopenia. However, these clinical signs responded favorably to steroid therapy. We reviewed 17 Japanese cases of M. genavense infection. All cases were in males; 7/17 (41%) were HIV-negative; and 12/17 (71%) had a decreased CD4 count. Genetic analysis confirmed M. genavense isolation, and macrolides were used universally. Mycobacterium genavense infection is challenging to identify and mimics other systemic inflammatory diseases such as sarcoidosis. There are no standard treatment protocols. Our case report and Japanese case review contribute to understanding this rare disease.

23 February 2024 in Respiratory Investigation
Verified
Journal Article
Closed access
HAHiroki Ashizawa
Hiroki Ashizawa
TTTakahiro Takazono
Takahiro Takazono
SKShin-Ya Kawashiri
Shin-Ya Kawashiri
NNNana Nakada
Nana Nakada
YIYuya Ito
Yuya Ito
HMHiroshi Mukae
Hiroshi Mukae

13 March 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
DSDaichi Setoguchi
Daichi Setoguchi
NINaoki Iwanaga
Naoki Iwanaga
YIYuya Ito
Yuya Ito
NANobuyuki Ashizawa
Nobuyuki Ashizawa
THTatsuro Hirayama
Tatsuro Hirayama
HMHiroshi Mukae
Hiroshi Mukae

23 September 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
NINaoki Iwanaga
Naoki Iwanaga
AOAyaka Ota
Ayaka Ota
HAHiroki Ashizawa
Hiroki Ashizawa
YIYuya Ito
Yuya Ito
THTatsuro Hirayama
Tatsuro Hirayama
HMHiroshi Mukae
Hiroshi Mukae
Objectives: In the present study, we aimed to clarify the mechanisms by which periodontal pathogens, particularly Prevotella intermedia, induce severe neutrophilic inflammation. In addition, we aimed to test the efficacy of macrolides, which has not been resolved in the neutrophilic inflammation induced by P. intermedia. Methods: NCl-H292 human airway epithelial cells were pre-incubated with clarithromycin for 2 h before incubation with P. intermedia supernatants. Then, C-X-C motif chemokine ligand 8 (CXCL8) transcription and interleukin (IL)-8 production were measured. To elucidate the signaling pathway, mitogen-activated protein kinase inhibitors were added to the cell culture, and the cells were subjected to Western blotting. Results:P. intermedia supernatants promoted CXCL8 transcription and IL-8 production, and the reactions were significantly suppressed by clarithromycin pretreatment. Only trametinib, the selective mitogen-activated extracellular signal-regulated kinase inhibitor, downregulated CXCL8 transcription and IL-8 production. Furthermore, Western blotting revealed that stimulation with P. intermedia supernatants specifically induces extracellular signal-regulated kinases (ERK) 1/2 phosphorylation, which is suppressed by clarithromycin pretreatment. Notably, the interference analysis revealed that ERK3 might be dispensable for IL-8 production under the stimulation of P. intermedia supernatants. Conclusions: Our results provide new insight into the mechanism underlying P. intermedia-induced production of IL-8 from human airway epithelial cells. Furthermore, macrolides might have therapeutic potential in regulating periodontal pathogen-induced neutrophilic inflammation in the lungs.